What You Should Know:
- Sequel Med Tech, LLC, a company focused on developing cutting-edge insulin delivery technologies, has announced that its innovative twiist™ Automated Insulin Delivery (AID) System, powered by Tidepool, will be the first to integrate Abbott’s FreeStyle Libre 3 Plus sensor, a continuous glucose monitoring (CGM) device.
- The integration marks a pivotal moment for individuals with type 1 diabetes (T1D). The twiist AID System, expected to launch in Q2 2025, is
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Senseonics and Ascensia Diabetes Care Integrate Eversense® 365 CGM with SweetSpot™ Platform
What You Should Know:
- Senseonics Holdings and Ascensia Diabetes Care today announced the integration of the Eversense® 365 Continuous Glucose Monitoring (CGM) System with the SweetSpot™ diabetes management platform in the U.S.
- The collaboration aims to improve patient care and streamline diabetes management for endocrinology practices and their patients.
Enhance Diabetes Management and Improve Patient Outcomes
The integration allows SweetSpot to seamlessly access and
Read More
Tandem Diabetes Care Receives FDA Clearance for Control-IQ+ Technology for Type 2 Diabetes
What You Should Know:
- Tandem Diabetes Care, a insulin delivery and diabetes technology company, announced that its Control-IQ+ technology has received clearance from the U.S. Food and Drug Administration (FDA) for use by adults with type 2 diabetes.
- The expanded indication builds on the success of Control-IQ+ in type 1 diabetes and offers a new automated insulin delivery (AID) option for individuals with type 2 diabetes.
Improve Glycemic Control for Adults with Type 2
Read More
GoodRx: The Average Price Per Insulin Unit Dropped 42%
What You Should Know:
- The average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19, in mid-2024, according to a new report from GoodRx. The drop represent the lowest average recorded in a decade.
- Thanks to the Inflation Reduction Act and voluntary price cuts by major insulin manufacturers, prices have seen significant declines. Products like Lantus, Novolin N, Humalog, and Humulin N are now more affordable than they have been in years.
Insulin Costs
Read More
Dexcom Introduces Generative AI Platform for Glucose Biosensing
What You Should Know:
- Dexcom, the global leader in continuous glucose monitoring (CGM), has achieved another groundbreaking milestone by launching the first generative AI (GenAI) platform in glucose biosensing technology, Stelo.
- The Stelo platform analyzes individual health data patterns to provide personalized insights and recommendations for improving metabolic health.
AI-Powered Personalized Guidance
The Dexcom GenAI platform leverages Google Cloud's Vertex AI and
Read More
Tandem t:slim X2 Pump Now Compatible with Dexcom G7 in Canada
What You Should Know:
- Tandem Diabetes Care, an insulin pump manufacturer, has announced expanded compatibility for its t:slim X2™ insulin pump in Canada.
- In-warranty users can now integrate their pumps with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems, providing greater flexibility and choice for diabetes management.
- The expanded compatibility with Dexcom G6 and G7 further enhances the pump's capabilities and provides users with greater
Read More
Abbott Opens State-of-the-Art Diabetes Care Manufacturing Facility in Kilkenny, Ireland
What You Should Know:
- Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland.
- Abbott's FreeStyle Libre portfolio is the world's leading continuous glucose monitoring system, helping more than 6 million people with diabetes across over 60 countries.
Boosting Irish Economy and Manufacturing Capabilities
The Kilkenny facility is part of a €440 million
Read More
Abbott’s FreeStyle Libre CGM Systems Now Cleared for Use During Imaging Procedures
What You Should Know:
- Abbott announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and MRIs.
- The development makes Abbott's systems the first and only patient-applied CGM sensors approved for use during these screenings, offering greater convenience and potential cost savings for people with diabetes.
Improving Diabetes
Read More
Glooko Secures $100M, Appoints Mike Alvarez as New CEO
- Glooko, a global digital health company, has announced a successful Series F funding round, raising $100M to fuel its continued growth and product development led by Georgian, with participation from Health Catalyst Capital, Canaan, and other investors.
- In addition to this significant investment, Glooko also announced the appointment of Mike Alvarez as its new Chief Executive Officer.
Funding to Drive Product Innovation and Global Expansion
This substantial investment will support
Read More
Study: Twin Health Treats Hypertension in Patients with Type 2 Diabetes
What You Should Know:
- Twin Health, a company known for its Digital Twin™ AI platform that helps individuals achieve remission of type 2 diabetes, has announced promising results in a new study focused on hypertension.
- Published in the Journal of the American College of Cardiology, the study demonstrates that the platform can effectively help users control blood pressure and reduce their reliance on medication.
Addressing the Link Between Diabetes and Hypertension
High
Read More
